Colorectal Cancer Rates Climb Across Nearly All Age Groups After Decades of Decline

After more than two decades of steady decline, colorectal cancer incidence in the United States rose in 2023 across nearly all age demographics. The reversal challenges previous assumptions that rising rates were strictly confined to early-onset cases in young adults.[1][6]

Data from the SEER 21 registry shows that the age-adjusted incidence rate of colorectal cancer fell from 55.2 per 100,000 people in 2000 to 36.7 in 2022. However, that long-term downward trend ended when the rate climbed to 38.3 per 100,000 in 2023.[1][6]

The SEER 21 registry, maintained by the National Cancer Institute, covers approximately 38 percent of the U.S. population and includes data on adults of any age. Public health experts had long regarded the two-decade decline in its incidence metrics as a durable success story driven by widespread colonoscopy adoption.[1][6]

The findings were published in the journal NEJM Evidence by a research team led by Caitlin Murphy, a professor of epidemiology and public health sciences at the University of Chicago. The analysis examined nationwide cancer data spanning a 20-year period.[6]

"Although modest, this apparent increase was the first since the inception of SEER 21 in 2000," the study authors wrote.[1]

The researchers noted that the upward trend remained consistent across sex, tumor subsite, diagnostic stage, and racial demographics. The shift indicates a broad, population-level change rather than an isolated anomaly.[1][6]

Expanding Beyond the Young

While early-onset colorectal cancer has dominated recent medical focus, the latest data indicates that rates are now increasing simultaneously across all age groups up to ages 65 to 69.[1][6]

The sharpest documented spike occurred among adults aged 45 to 49, where incidence rates rose by 12.76 percent annually between 2019 and 2023. Public health experts attribute a portion of this specific surge to updated national guidelines that lowered the recommended screening age from 50 to 45.[6]

Catching cancer earlier through expanded screening is a positive outcome, but researchers emphasize that the screening effect cannot explain the broader incidence rise across older and younger cohorts. The data points to a systemic shift in how and when the disease develops.[6]

The study authors investigated whether the 2023 uptick was simply a backlog of delayed diagnoses from the COVID-19 pandemic. They concluded that while post-pandemic catch-up cannot be entirely excluded, it is unlikely to account for the full magnitude of the increase.[1]

Instead, epidemiologists point to a birth cohort effect. Adults born since the 1960s appear to carry an elevated risk of colorectal cancer as they age into middle and older adulthood, suggesting that environmental or lifestyle exposures early in life are manifesting decades later.[1][6]

This cohort effect implies that the risk profile is moving through the population over time. As individuals exposed to modern dietary and environmental changes in their youth grow older, they carry that elevated baseline risk into their senior years, fundamentally altering the disease's epidemiology.[1][6]

A Sixfold Rise in Children

The broader demographic shift coincides with an alarming, though numerically rare, surge in pediatric cases. A recent analysis of Centers for Disease Control and Prevention data revealed a sixfold increase in colorectal cancer among young children over the past two decades.[2][7]

In 1999, the diagnosis rate for children ages 10 to 14 was just one in a million. By 2020, that figure had climbed to six in a million, representing a stark relative increase despite the low absolute numbers.[2]

Teenagers have experienced a similar, troubling trajectory. For adolescents between the ages of 15 and 19, the rate of diagnosis more than quadrupled, jumping from three in a million in 1999 to 13 in a million by 2020.[2][7]

Separate research presented at the American Academy of Pediatrics annual meeting in October analyzed the clinical histories of 84 pediatric patients diagnosed between 2012 and 2023. The median age of diagnosis in this specific cohort was just 16 years old.[2]

These young patients often presented with highly aggressive forms of the disease. Furthermore, they experienced gastrointestinal symptoms for a median duration of 12 weeks before physicians reached a definitive cancer diagnosis.[2]

Only about 20 percent of the pediatric patients in the study had a close relative with colorectal cancer. This low rate of familial connection suggests that hereditary genetics alone cannot explain the sudden emergence of the disease in youth.[2]

Searching for Environmental Triggers

Dr. Christopher Lieu, a medical oncologist, noted the unusual presentation in younger patients.[2]

"Some of that might be related to delays in diagnosis," Lieu said, "but if you want my honest opinion, it does suggest that these cancers are developing differently."[2]

Researchers are racing to identify the environmental and lifestyle factors driving this cross-generational surge. Investigations are currently focusing on the microbiome, the widespread consumption of ultra-processed foods, early childhood antibiotic exposure, and emerging environmental toxins like microplastics.[2][7]

The biological mechanisms linking these modern exposures to tumor development remain under intense scrutiny. Scientists hypothesize that chronic inflammation, driven by a disrupted gut microbiome, may be accelerating cellular mutations in the intestinal lining long before traditional age-related risks emerge.[2][7]

The simultaneous rise across almost all age groups presents a looming challenge for the American healthcare system. As the upward trend spreads, the demand for complex oncological treatment and long-term survivorship management is expected to increase significantly.[5][6]

While colorectal cancer remains largely a disease of age, with 55 percent of cases still diagnosed in people over 65, the 2023 data marks a critical turning point. A disease that was steadily retreating is now advancing on multiple demographic fronts.[2][6]